Literature DB >> 14673581

Assessment of complex movements reflects dysfunction in Huntington's disease.

Carsten Saft1, Jürgen Andrich, Nina-Marie Meisel, Horst Przuntek, Thomas Müller.   

Abstract

Results of various complex instrumental tools, rating scales, caudate atrophy and CAG repeat length may reflect the severity of Huntington's disease (HD). A simple assessment task for dysfunction due to disease is the standardized, computer based performance of peg insertion. The objectives of our study were to compare scored HD symptoms, computed bicaudate diameter ratio (BDR), age related genetic disease load (CAG index = [CAG-35.5 x age]) and peg insertion scores between asymptomatic 34 HD gene carriers, 89 previously untreated HD patients with psychiatric or motor symptoms, or both, and 51 treated HD patients. We measured the period of the total time taken to insert 25 pegs from a rack into a series of appropriate holes, calculated the CAG index, estimated the bicaudate diameter ratio (BDR) of a current brain CT and scored the HD patients under blind conditions. Times for the peg insertion task significantly differed between HD patients and controls, but not between HD gene carriers and controls. BDR and CAG index reflected the increase of symptoms in HD. Peg insertion results and scored severity of HD, BDR and CAG index significantly correlated with each other. Peg insertion scores are not specific diagnostic markers for HD, but they reflect clinical symptoms of neurodegeneration. The performance of peg insertion involves visuospatial cognition, self-elaboration of internal strategies, sorting and planning of movement. Therefore peg insertion particularly reflects executive dysfunction in early HD and additionally motor impairment in advanced HD.

Entities:  

Mesh:

Year:  2003        PMID: 14673581     DOI: 10.1007/s00415-003-0256-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Impaired motor speech performance in Huntington's disease.

Authors:  Sabine Skodda; Uwe Schlegel; Rainer Hoffmann; Carsten Saft
Journal:  J Neural Transm (Vienna)       Date:  2013-11-13       Impact factor: 3.575

2.  Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease.

Authors:  Andreas Matusch; Carsten Saft; David Elmenhorst; Peter H Kraus; Ralf Gold; Hans-Peter Hartung; Andreas Bauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-25       Impact factor: 9.236

3.  Functional connectivity of the prefrontal cortex in Huntington's disease.

Authors:  D R Thiruvady; N Georgiou-Karistianis; G F Egan; S Ray; A Sritharan; M Farrow; A Churchyard; P Chua; J L Bradshaw; T-L Brawn; R Cunnington
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-06       Impact factor: 10.154

4.  Assessment of simple movements and progression of Huntington's disease.

Authors:  Jürgen Andrich; Carsten Saft; Natalie Ostholt; Thomas Müller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

5.  Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.

Authors:  C Saft; J E Andrich; N Brune; M Gencik; P H Kraus; H Przuntek; J T Epplen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

6.  Music perception and movement deterioration in Huntington's disease.

Authors:  Christian Beste; Anne Schüttke; Bettina Pfleiderer; Carsten Saft
Journal:  PLoS Curr       Date:  2011-09-20

7.  No evidence of impaired gastric emptying in early Huntington's Disease.

Authors:  Carsten Saft; Jürgen Andrich; Marc Fälker; Sarah Gauda; Sina Küchler; Dirk Woitalla; Oliver Goetze
Journal:  PLoS Curr       Date:  2011-10-25

8.  Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

Authors:  Carsten Saft; Thorsten Lauter; Peter H Kraus; Horst Przuntek; Juergen E Andrich
Journal:  BMC Neurol       Date:  2006-02-28       Impact factor: 2.474

9.  Rivastigmine in the treatment of patients with Alzheimer's disease.

Authors:  Thomas Müller
Journal:  Neuropsychiatr Dis Treat       Date:  2007-04       Impact factor: 2.570

10.  Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues.

Authors:  Jessica Despard; Anne-Marie Ternes; Bleydy Dimech-Betancourt; Govinda Poudel; Andrew Churchyard; Nellie Georgiou-Karistianis
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.